The price of Sharps Technology Inc (NASDAQ:STSS) shares last traded on Wall Street rose 141.44% to $0.52.
STSS stock price is now 81.96% away from the 50-day moving average and 18.27% away from the 200-day moving average. The market capitalization of the company currently stands at $8.11M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, Hayes Robert Michael, Chief Executive Officer bought 10,000 shares of the company’s stock on Feb 20 ’24. The stock was bought for $3,400 at an average price of $0.34. Upon completion of the transaction, the Chief Executive Officer now directly owns 95,882 shares in the company, valued at $49858.64. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 06 ’24, Chief Executive Officer Hayes Robert Michael bought 10,000 shares of the business’s stock. A total of $2,900 was incurred on buying the stock at an average price of $0.29. This leaves the insider owning 85,882 shares of the company worth $44658.64. A total of 8.51% of the company’s stock is owned by insiders.
During the past 12 months, Sharps Technology Inc has had a low of $0.17 and a high of $1.13. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.15, and a quick ratio of 0.49. The fifty day moving average price for STSS is $0.28436 and a two-hundred day moving average price translates $0.437505 for the stock.
The latest earnings results from Sharps Technology Inc (NASDAQ: STSS) was released for 2024-03-31. For the current quarter, analysts expect STSS to generate $7.24B in revenue.
Sharps Technology Inc(STSS) Company Profile
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
